• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of biochemjBJ Latest papers and much more!
Biochem J. May 1, 1998; 331(Pt 3): 727–732.
PMCID: PMC1219411

Human cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix.


Cathepsin K (EC is a recently described enzyme that has been shown to cleave type I collagen in its triple helix. The aim of this study was to determine if it also cleaves type II collagen in the triple helix and to identify the helical cleavage site(s) in types I and II collagens. Soluble human and bovine type II collagen, and rat type I collagen, were incubated with cathepsin K before the reaction was stopped with trans-epoxysuccinyl-l-leucylamido-(4-guanidino)butane (E-64). Analysis by SDS/PAGE of the collagen digests showed that optimal activity of cathepsin K against native type II collagen was between pH 5.0 and 5.5 and against denatured collagen between pH 4.0 and 7.0. The enzyme cleaved telopeptides as well as the alpha1(II) chains, generating multiple fragments in the range 90-120 kDa. The collagenolytic activity was not due to a contaminating metalloenzyme or serine proteinase as it was not inhibited by 1,10-phenanthroline, EDTA or 3,4-dichloroisocoumarin. Western blotting with anti-peptide antibodies to different regions of the alpha1(II) chain suggested that cathepsin K cleaved native alpha1(II) chains in the N-terminal region of the helical domain rather than at the well-defined collagenase cleavage site. This was confirmed by N-terminal sequencing of one of the fragments, revealing cleavage at a Gly-Lys bond, 58 residues from the N-terminus of the helical domain. By using a similar approach, cathepsin K was found to cleave native type I collagen close to the N-terminus of its triple helix. These results indicate that cathepsin K could have a role in the turnover of type II collagen, as well as type I collagen.

Full Text

The Full Text of this article is available as a PDF (344K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, Poole AR. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest. 1994 Apr;93(4):1722–1732. [PMC free article] [PubMed]
  • Everts V, van der Zee E, Creemers L, Beertsen W. Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J. 1996 Apr;28(4):229–245. [PubMed]
  • Barrett AJ. The possible role of neutrophil proteinases in damage to articular cartilage. Agents Actions. 1978 Jan;8(1-2):11–18. [PubMed]
  • Gross J, Nagai Y. Specific degradation of the collagen molecule by tadpole collagenolytic enzyme. Proc Natl Acad Sci U S A. 1965 Oct;54(4):1197–1204. [PMC free article] [PubMed]
  • Mainardi CL, Pourmotabbed TF, Hasty KA. Inflammatory phagocytes and connective tissue degrading metalloproteinases. Am J Med Sci. 1991 Sep;302(3):171–175. [PubMed]
  • Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest. 1996 Feb 1;97(3):761–768. [PMC free article] [PubMed]
  • Knäuper V, López-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem. 1996 Jan 19;271(3):1544–1550. [PubMed]
  • Welgus HG, Jeffrey JJ, Stricklin GP, Eisen AZ. The gelatinolytic activity of human skin fibroblast collagenase. J Biol Chem. 1982 Oct 10;257(19):11534–11539. [PubMed]
  • Garbisa S, Ballin M, Daga-Gordini D, Fastelli G, Naturale M, Negro A, Semenzato G, Liotta LA. Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes. J Biol Chem. 1986 Feb 15;261(5):2369–2375. [PubMed]
  • Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainardi CL. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem. 1985 Feb 25;260(4):2493–2500. [PubMed]
  • Starkey PM, Barrett AJ, Burleigh MC. The degradation of articular collagen by neutrophil proteinases. Biochim Biophys Acta. 1977 Aug 11;483(2):386–397. [PubMed]
  • Saksela O. Plasminogen activation and regulation of pericellular proteolysis. Biochim Biophys Acta. 1985 Nov 12;823(1):35–65. [PubMed]
  • Hayashi H. The intracellular neutral SH-dependent protease associated with inflammatory reactions. Int Rev Cytol. 1975;40:101–151. [PubMed]
  • Brömme D, Okamoto K, Wang BB, Biroc S. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem. 1996 Jan 26;271(4):2126–2132. [PubMed]
  • Kirschke H, Kembhavi AA, Bohley P, Barrett AJ. Action of rat liver cathepsin L on collagen and other substrates. Biochem J. 1982 Feb 1;201(2):367–372. [PMC free article] [PubMed]
  • Hill PA, Murphy G, Docherty AJ, Hembry RM, Millican TA, Reynolds JJ, Meikle MC. The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci. 1994 Nov;107(Pt 11):3055–3064. [PubMed]
  • Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ, Meikle MC. Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem. 1994 Sep;56(1):118–130. [PubMed]
  • Nguyen Q, Mort JS, Roughley PJ. Cartilage proteoglycan aggregate is degraded more extensively by cathepsin L than by cathepsin B. Biochem J. 1990 Mar 1;266(2):569–573. [PMC free article] [PubMed]
  • Gabrijelcic D, Annan-Prah A, Rodic B, Rozman B, Cotic V, Turk V. Determination of cathepsins B and H in sera and synovial fluids of patients with different joint diseases. J Clin Chem Clin Biochem. 1990 Mar;28(3):149–153. [PubMed]
  • Trabandt A, Gay RE, Fassbender HG, Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum. 1991 Nov;34(11):1444–1451. [PubMed]
  • Van Noorden CJ, Smith RE, Rasnick D. Cysteine proteinase activity in arthritic rat knee joints and the effects of a selective systemic inhibitor, Z-Phe-AlaCH2F. J Rheumatol. 1988 Oct;15(10):1525–1535. [PubMed]
  • Etherington DJ, Taylor MA, Henderson B. Elevation of cathepsin L levels in the synovial lining of rabbits with antigen-induced arthritis. Br J Exp Pathol. 1988 Apr;69(2):281–289. [PMC free article] [PubMed]
  • Esser RE, Watts LM, Angelo RA, Thornburg LP, Prior JJ, Palmer JT. The effects of fluoromethyl ketone inhibitors of cathepsin B on adjuvant induced arthritis. J Rheumatol. 1993 Jul;20(7):1176–1183. [PubMed]
  • Blair HC, Teitelbaum SL, Grosso LE, Lacey DL, Tan HL, McCourt DW, Jeffrey JJ. Extracellular-matrix degradation at acid pH. Avian osteoclast acid collagenase isolation and characterization. Biochem J. 1993 Mar 15;290(Pt 3):873–884. [PMC free article] [PubMed]
  • Brömme D, Okamoto K. Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe Seyler. 1995 Jun;376(6):379–384. [PubMed]
  • Rawlings ND, Barrett AJ. Families of cysteine peptidases. Methods Enzymol. 1994;244:461–486. [PubMed]
  • Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, Lee-Rykaczewski E, Coleman L, Rieman D, Barthlow R, et al. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem. 1996 May 24;271(21):12511–12516. [PubMed]
  • Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 1996 Aug 30;273(5279):1236–1238. [PubMed]
  • Rantakokko J, Aro HT, Savontaus M, Vuorio E. Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett. 1996 Sep 16;393(2-3):307–313. [PubMed]
  • Dodge GR, Poole AR. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest. 1989 Feb;83(2):647–661. [PMC free article] [PubMed]
  • Epstein EH., Jr (Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life. J Biol Chem. 1974 May 25;249(10):3225–3231. [PubMed]
  • Cawston TE, Barrett AJ. A rapid and reproducible assay for collagenase using [1-14C]acetylated collagen. Anal Biochem. 1979 Nov 1;99(2):340–345. [PubMed]
  • Buttle DJ. Glycyl endopeptidase. Methods Enzymol. 1994;244:539–555. [PubMed]
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Dunbar B, Wilson SB. A buffer exchange procedure giving enhanced resolution to polyacrylamide gels prerun for protein sequencing. Anal Biochem. 1994 Jan;216(1):227–228. [PubMed]
  • Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, Mitchell P, Hambor J, Diekmann O, Tschesche H, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest. 1997 Apr 1;99(7):1534–1545. [PMC free article] [PubMed]
  • Birkedal-Hansen H. Catabolism and turnover of collagens: collagenases. Methods Enzymol. 1987;144:140–171. [PubMed]
  • Maciewicz RA, Wotton SF, Etherington DJ, Duance VC. Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L. FEBS Lett. 1990 Aug 20;269(1):189–193. [PubMed]
  • Burleigh MC, Barrett AJ, Lazarus GS. Cathepsin B1. A lysosomal enzyme that degrades native collagen. Biochem J. 1974 Feb;137(2):387–398. [PMC free article] [PubMed]
  • Highberger JH, Corbett C, Gross J. Isolation and characterization of a peptide containing the site of cleavage of the chick skin collagen alpha 1[I] chain by animal collagenases. Biochem Biophys Res Commun. 1979 Jul 12;89(1):202–208. [PubMed]
  • Li J, Brick P, O'Hare MC, Skarzynski T, Lloyd LF, Curry VA, Clark IM, Bigg HF, Hazleman BL, Cawston TE, et al. Structure of full-length porcine synovial collagenase reveals a C-terminal domain containing a calcium-linked, four-bladed beta-propeller. Structure. 1995 Jun 15;3(6):541–549. [PubMed]
  • Aibe K, Yazawa H, Abe K, Teramura K, Kumegawa M, Kawashima H, Honda K. Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol Pharm Bull. 1996 Aug;19(8):1026–1031. [PubMed]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...